The awards are presented annually to organizations in the Greater Philadelphia and Triangle (North Carolina) regions.
GSK has announced positive headline outcomes from a Phase III trial of Blenrep with bortezomib and dexamethasone for multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback